208 related articles for article (PubMed ID: 16099408)
21. Comparative immunohistochemical study of group II (synovial-type) and group IV (cytosolic) phospholipases A2 in disc prolapse tissue.
Habtemariam A; Grönblad M; Virri J; Airaksinen O; Luukkonen M; Turunen V; Savolainen S; Karaharju E
Eur Spine J; 1998; 7(5):387-93. PubMed ID: 9840472
[TBL] [Abstract][Full Text] [Related]
22. Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2.
Street IP; Lin HK; Laliberté F; Ghomashchi F; Wang Z; Perrier H; Tremblay NM; Huang Z; Weech PK; Gelb MH
Biochemistry; 1993 Jun; 32(23):5935-40. PubMed ID: 8018213
[TBL] [Abstract][Full Text] [Related]
23. Identification and distribution of endoplasmic reticulum iPLA2.
Kinsey GR; Cummings BS; Beckett CS; Saavedra G; Zhang W; McHowat J; Schnellmann RG
Biochem Biophys Res Commun; 2005 Feb; 327(1):287-93. PubMed ID: 15629460
[TBL] [Abstract][Full Text] [Related]
24. PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS.
Kessen UA; Schaloske RH; Stephens DL; Killermann Lucas K; Dennis EA
J Lipid Res; 2005 Nov; 46(11):2488-96. PubMed ID: 16150819
[TBL] [Abstract][Full Text] [Related]
25. The rat ovarian phospholipase A2 system: gene expression, cellular localization, activity characterization, and interleukin-1 dependence.
Kol S; Ruutiainen-Altman K; Ben-Shlomo I; Payne DW; Ando M; Adashi EY
Endocrinology; 1997 Jan; 138(1):322-31. PubMed ID: 8977420
[TBL] [Abstract][Full Text] [Related]
26. Specific roles for Group V secretory PLA₂ in retinal iron-induced oxidative stress. Implications for age-related macular degeneration.
Rodríguez Diez G; Sánchez Campos S; Giusto NM; Salvador GA
Exp Eye Res; 2013 Aug; 113():172-81. PubMed ID: 23791636
[TBL] [Abstract][Full Text] [Related]
27. Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils.
Flamand N; Picard S; Lemieux L; Pouliot M; Bourgoin SG; Borgeat P
Br J Pharmacol; 2006 Oct; 149(4):385-92. PubMed ID: 16967052
[TBL] [Abstract][Full Text] [Related]
28. VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2.
Bernatchez PN; Winstead MV; Dennis EA; Sirois MG
Br J Pharmacol; 2001 Sep; 134(1):197-205. PubMed ID: 11522612
[TBL] [Abstract][Full Text] [Related]
29. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
[TBL] [Abstract][Full Text] [Related]
30. Human retinal pigment epithelium secretes a phospholipase A2 and contains two novel intracellular phospholipases A2.
Van Themsche C; Jacob M; Salesse C
Biochem Cell Biol; 2001; 79(1):1-10. PubMed ID: 11235912
[TBL] [Abstract][Full Text] [Related]
31. Involvement of Ca2+-independent phospholipase A2 in the translocation of hypoxia-inducible factor-1alpha to the nucleus under hypoxic conditions.
Osada-Oka M; Takahashi M; Akiba S; Sato T
Eur J Pharmacol; 2006 Nov; 549(1-3):58-62. PubMed ID: 16979159
[TBL] [Abstract][Full Text] [Related]
32. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
Morioka Y; Saiga A; Yokota Y; Suzuki N; Ikeda M; Ono T; Nakano K; Fujii N; Ishizaki J; Arita H; Hanasaki K
Arch Biochem Biophys; 2000 Sep; 381(1):31-42. PubMed ID: 11019817
[TBL] [Abstract][Full Text] [Related]
33. Membrane Association Allosterically Regulates Phospholipase A
Mouchlis VD; Dennis EA
Acc Chem Res; 2022 Dec; 55(23):3303-3311. PubMed ID: 36315840
[TBL] [Abstract][Full Text] [Related]
34. [Diversity of phospholipases A2 and their functions].
Bereziat G
C R Seances Soc Biol Fil; 1996; 190(4):409-16. PubMed ID: 8952891
[TBL] [Abstract][Full Text] [Related]
35. Phospholipase A2 superfamily members play divergent roles after spinal cord injury.
López-Vales R; Ghasemlou N; Redensek A; Kerr BJ; Barbayianni E; Antonopoulou G; Baskakis C; Rathore KI; Constantinou-Kokotou V; Stephens D; Shimizu T; Dennis EA; Kokotos G; David S
FASEB J; 2011 Dec; 25(12):4240-52. PubMed ID: 21868473
[TBL] [Abstract][Full Text] [Related]
36. Cytosolic phospholipase A2 inhibition attenuates ischemia-reperfusion injury in an isolated rat lung model.
Bellido-Reyes YA; Akamatsu H; Kojima K; Arai H; Tanaka H; Sunamori M
Transplantation; 2006 Jun; 81(12):1700-7. PubMed ID: 16794537
[TBL] [Abstract][Full Text] [Related]
37. Phospholipase A2 Isoforms as Novel Targets for Prevention and Treatment of Inflammatory and Oncologic Diseases.
Yarla NS; Bishayee A; Vadlakonda L; Chintala R; Duddukuri GR; Reddanna P; Dowluru KS
Curr Drug Targets; 2016; 17(16):1940-1962. PubMed ID: 26212262
[TBL] [Abstract][Full Text] [Related]
38. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia.
Muralikrishna Adibhatla R; Hatcher JF
Free Radic Biol Med; 2006 Feb; 40(3):376-87. PubMed ID: 16443152
[TBL] [Abstract][Full Text] [Related]
39. Assessing phospholipase A2 activity toward cardiolipin by mass spectrometry.
Hsu YH; Dumlao DS; Cao J; Dennis EA
PLoS One; 2013; 8(3):e59267. PubMed ID: 23533611
[TBL] [Abstract][Full Text] [Related]
40. Complement-induced phospholipase A2 activation in experimental membranous nephropathy.
Cybulsky AV; Takano T; Papillon J; McTavish AJ
Kidney Int; 2000 Mar; 57(3):1052-62. PubMed ID: 10720957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
